Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 43547-331

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 43547-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1a (22bf08c2 615b 4b48 Af36 1b71a91459dc 01)

A line graph depicting the relationship between baseline systolic blood pressure (SBP) and the percentage of subjects with SBP less than 140 mmHg. The graph includes data series labeled as average and individual results from Study V and Study VI, differentiating between average and irbesartan-specific values.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 1b (22bf08c2 615b 4b48 Af36 1b71a91459dc 02)

A line graph depicting the percentage of subjects with systolic blood pressure (SBP) ≤130 mmHg relative to baseline SBP values (mmHg). The graph compares multiple studies, including combined average, Irbesartan (Irb) studies V and VI, Hydrochlorothiazide (HCTZ) study V, and average study V, with separate lines representing each data set.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2a (22bf08c2 615b 4b48 Af36 1b71a91459dc 03)

A line graph depicting the reduction in diastolic blood pressure (DBP in mmHg) over a range of baseline DBP values (90 to 130 mmHg). The graph compares average study data and results for Irbesartan and Hydrochlorothiazide (HCTZ) from two separate studies, Study V and Study VI, showing percentage DBP reduction on the vertical axis and baseline DBP on the horizontal axis.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 2b (22bf08c2 615b 4b48 Af36 1b71a91459dc 04)

A line graph showing the percentage decrease in diastolic blood pressure (DBP) from baseline across different study groups, including average study V, Irbesartan (Irb.), hydrochlorothiazide (HCTZ) study V, average study VI, and Irbesartan study VI. The x-axis represents baseline DBP in mmHg, and the y-axis represents the percentage decrease in DBP below 80 mmHg.*

FDA Label Image

Chemical Structure Irbesartan (22bf08c2 615b 4b48 Af36 1b71a91459dc 05)

Chemical structure diagram of the active ingredients Irbesartan and Hydrochlorothiazide, showing molecular bonds and arrangements typical of these compounds.*

FDA Label Image

Chemical Structure Hydrochlorothiazide (22bf08c2 615b 4b48 Af36 1b71a91459dc 06)

Chemical structure of the active ingredient Irbesartan, showing its molecular arrangement including sulfonamide, chlorine, and other functional groups.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 3 (22bf08c2 615b 4b48 Af36 1b71a91459dc 07)

A scatter plot with a curve showing the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis. Data points indicate individual values, illustrating dose-dependent effects up to approximately 900 mg/day.*

FDA Label Image

Irbesartan And Hydrochlorothiazide Figure 4 (22bf08c2 615b 4b48 Af36 1b71a91459dc 08)

A scatter plot graph showing the placebo-subtracted reduction in trough SeDBP (systolic endpoint diastolic blood pressure) as a function of Irbesartan dose in mg/day. The graph includes data points and a fitted curve depicting the dose-response relationship.*

FDA Label Image

Irbesartan And Hydrochlorothiazide 150-12.5 mg (22bf08c2 615b 4b48 Af36 1b71a91459dc 09)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg oral tablets. The package contains 30 tablets and is labeled for prescription use only. Manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. and distributed by Solco Healthcare US, LLC. Storage instructions and barcode are visible.*

FDA Label Image

Irbesartan And Hydrochlorothiazide 300/12.5 mg (22bf08c2 615b 4b48 Af36 1b71a91459dc 10)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP showing strength of 300 mg Irbesartan and 12.5 mg Hydrochlorothiazide per tablet. The label indicates 30 tablets per container, with Solco Healthcare US, LLC as the distributor. Storage instructions and manufacturer details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.